Noubar Afeyan ✓

@NoubarAfeyan · Cambridge, MA · joined 19 Oct 2013

Pioneering innovations for a better future for people & the planet. Founder & CEO @FlagshipPioneer, the life sciences co that founded @moderna_tx and many more.

13 914Followers

250Following

2 421Posts total

27.9KViews on collected posts

Against accounts of the same size

7 posts from the last 90 days, next to the 10K–100K follower range. shown widely, but few of those viewers react.

Median views2 816this account2 043median for 10K–100K

Reach, %20.24%this account6.16%median for 10K–100K

Engagement, %0.84%this account1.59%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	2 816	2 043	1.38×
Reach (views ÷ followers)	20.24%	6.16%	3.29×
Engagement rate	0.84%	1.59%	0.53×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.8K10 Aug

2K25 Aug

13K26 Aug

2.9K27 Aug

1.4K

2.3K1 Sep

3.6K2 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

2.24%10 Aug

3.83%25 Aug

0.84%26 Aug

0.17%27 Aug

0.91%

0.30%1 Sep

0.70%2 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.59%.

What the audience does

Likes72.7%242 in total

Reposts10.8%36 in total

Replies3.6%12 in total

Quotes2.4%8 in total

Bookmarks10.5%35 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Glad to join @LizClaman on @FoxBusiness to discuss the @moderna_tx @Merck clinical trial and what it means for cancer treatment. 3.6K views · 20 likes · 2 reposts · 2 replies 02 Sep 2026 Watch now: Flagship Founder & CEO @NoubarAfeyan joins The Claman Report to discuss @moderna_tx and @Merck's mRNA-based cancer therapy. 2.3K views · 6 likes · 0 reposts · 0 replies 01 Sep 2026 Congratulations to our @ProFoundTx and @gatesfoundation on this innovative investment agreement. Eclampsia and preeclampsia affect millions of mothers and babies each year, but are woefully understudied. Combining this new support from the Gates Foundation with ProFound’s 1.4K views · 11 likes · 2 reposts · 0 replies 27 Aug 2026 Today we announced an investment from @gatesfoundation to discover new medicines for preeclampsia/eclampsia. Using our ProFoundry™ Platform & AI, we will explore the expanded proteome to understand the biology affecting mothers & babies at risk. Details: https://t.co/3sp8 2.9K views · 3 likes · 0 reposts · 0 replies 27 Aug 2026 Pancreatic cancer was long considered one of medicine’s deadliest diagnoses. But today, the FDA approved @RevMedicines' Daraxonrasib - a new treatment that has in trials nearly doubled how long patients survive compared to standard chemotherapy. Daraxonrasib works by targeting a 13K views · 89 likes · 15 reposts · 3 replies 26 Aug 2026 As a teenager in Montreal listening to “9 to 5,” I never imagined my path would one day cross with Dolly Parton’s. But during COVID, Dolly’s support of Vanderbilt helped fund early tests for Moderna’s vaccine. Later, she encouraged her fans to get vaccinated as only she could (I 2K views · 66 likes · 8 reposts · 1 replies 25 Aug 2026 When I first immigrated to the U.S., I felt out of place – until I realized that except for Native Americans, everyone in this country is or once was from somewhere else. I enjoyed the @nytimes' compelling analysis of that history, which uses Census data to visualize the https:// 2.8K views · 47 likes · 9 reposts · 6 replies 10 Aug 2026